Platform Centers / Hubs
PHRT has established two platforms in Switzerland for large clinical sample cohorts, that generate consistent, high quality genomic, transcriptomic and proteomic data. Each platform has the capacity to process several thousand samples per year. Both platforms offer processing of primary digital data collected from the samples to the stage of quantitative profiles. Both platforms have been extensively bench-marked and are operational.
Health 2030 Genome Center (Genomic Platform)
Clinical Proteotype Analysis Center (Proteomic Platform)
The Clinical Proteotype Analysis Center in Zurich is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of disease/wellness, through the development and application of robust,quantitative,mass spectrometry-based strategies.
Further information (fact sheet, PDF).
Clinical Metabolomics and Lipidomics Center
The Clinical Metabolomics and Lipidomics Center provides untargeted and high-throughput methods for the unbiased analysis of human samples. It is ideally suited for biomarker discovery in large cohorts, and ideally complements genomics and proteomics analyses with a functional readout. The Center is located in Zurich, and cooperates tightly with the Proteomics platform to provide a one-stop shop for clinical mass spectrometry.